Even with bronchodilator and steroid treatment, many people with COPD continue to have symptom flare-ups. "For some of these patients, treatment with a biologic may offer a promising option ...

PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax. Ben Knox ...

Notably, the likelihood for bronchodilator responsiveness per the 2005 definition significantly went down with testing in autumn vs. winter (aOR = 0.67; 95% CI, 0.48-0.92), according to the study.

Combined treatment with bronchodilator drugs and steroids resulted in a mean increase in vital capacity and first-second volume of almost 50 per cent of the pretreatment value.

"Little Evidence Behind Bronchodilator Therapy For Cystic Fibrosis." ScienceDaily. ScienceDaily, 26 October 2005. <www.sciencedaily.com / releases / 2005 / 10 / 051026085739.htm>.

Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More patients in this group vs. the low responsiveness group used high-dose inhaled ...

Lipari M, Pramodini KPB, Wilhelm SM. Dual-versus mono-bronchodilator therapy in moderate to severe COPD [published online June 4, 2020]. Annals of Pharmacotherapy. doi: 10.1177/1060028020932134.

Cite this: Unpredictability of Deception in Compliance With Physician-Prescribed Bronchodilator Inhaler Use in a Clinical Trial - Medscape - Aug 01, 2000.

Conclusions Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in symptomatic, tobacco-exposed persons with preserved lung function as assessed by spirometry.

Each patient's bronchodilator responsiveness (BDR) was determined by three measures: absolute change in the volume of air exhaled during a forced breath in one second (FEV1) (BDRABS); change as ...